Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
TTRX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $367.45M
- EPS (TTM)
- -$0.29
- Dividend yield
- None
- 52-week range
- 2.57 – 26.50
- Day range
- 11.31 – 13.03
- Volume / Avg
- 171.50K / 114.62K
- Beta
- —
- Shares outstanding
- 30.37M
- Next earnings
- Nov 12, 2026
52-week range
TTRX stock today
On Oct 7, TTRX ended the session at $12.10, adding $0.46 (3.95%), versus the S&P 500's 0.22% decline. At this level, TTRX sits in the middle of its 52-week range of $2.57 to $26.50: 54.3% below the high and 370.8% above the low. Turn Therapeutics has posted a net loss over the last twelve months (EPS of -$0.29), so its P/E ratio is not meaningful.
Turn Therapeutics's next earnings report is expected on Nov 12, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Turn Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 12, 2026
Turn Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RLMDRelmada Therapeutics Inc. | 3.25 | -0.91% | $346.68M | vs TTRX |
| ENTAEnanta Pharmaceuticals Inc. | 12.37 | +1.64% | $360.28M | vs TTRX |
| EBSEmergent BioSolutions Inc. | 7.07 | +1.73% | $362.50M | vs TTRX |
| ARCTArcturus Therapeutics Holdings Inc. | 12.77 | -1.81% | $362.82M | vs TTRX |
| CYPHCypherpunk Technologies Inc. | 3.05 | -6.44% | $328.68M | vs TTRX |
| GALTGalectin Therapeutics Inc. | 3.62 | -3.72% | $365.08M | vs TTRX |
| IRDOpus Genetics Inc. | 4.41 | +0.68% | $366.89M | vs TTRX |
| BNTCBenitec Biopharma Inc. | 8.99 | -0.11% | $313.60M | vs TTRX |
Indexes, lists and sector
Largest Health Care stocks
Turn Therapeutics stock FAQ
What is Turn Therapeutics's stock price today?
TTRX last traded at $12.10 as of Oct 7, 4:00 PM EDT, up 3.95% on the day. Prices are delayed at least 15 minutes.
When is Turn Therapeutics's next earnings date?
Turn Therapeutics is expected to report earnings on Thursday, November 12, 2026.
What is the TTRX 52-week high?
The 52-week high for TTRX is $26.50 and the 52-week low is $2.57. The stock is currently 54.3% below its high.